cagrilintide semaglutide cagrisema phase 3 results 2024 2025 Novo Nordisk affirms 25% weight-loss expectation for experimental drug Efficacy and safety of co-administered

After screening of titles and abstract, and removal of the results overlapping with the previous search, 16 additional papers were selected as relevant for the review

Deficiency primarily occurs in people with lipid malabsorption problems or Ataxia with Isolated Vitamin E Deficiency (AVED)

Additionally, the study does not differentiate between clear liquids and solid contents within the high-risk group as well as doesnt provide the actual volume residual gastric content

These precautions align with the NHS Pharmaceutical Quality Assurance Committee (PQAC) Yellow Cover Document on Quality Assurance of Aseptic Preparation Services and the MHRA Orange Guide